JP2004525983A5 - - Google Patents

Download PDF

Info

Publication number
JP2004525983A5
JP2004525983A5 JP2002583415A JP2002583415A JP2004525983A5 JP 2004525983 A5 JP2004525983 A5 JP 2004525983A5 JP 2002583415 A JP2002583415 A JP 2002583415A JP 2002583415 A JP2002583415 A JP 2002583415A JP 2004525983 A5 JP2004525983 A5 JP 2004525983A5
Authority
JP
Japan
Prior art keywords
group
hydrogen atom
those
preferred compounds
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002583415A
Other languages
English (en)
Japanese (ja)
Other versions
JP4324382B2 (ja
JP2004525983A (ja
Filing date
Publication date
Priority claimed from FR0105360A external-priority patent/FR2823748B1/fr
Priority claimed from FR0105362A external-priority patent/FR2823750B1/fr
Application filed filed Critical
Priority claimed from PCT/FR2002/001343 external-priority patent/WO2002085888A1/fr
Publication of JP2004525983A publication Critical patent/JP2004525983A/ja
Publication of JP2004525983A5 publication Critical patent/JP2004525983A5/ja
Application granted granted Critical
Publication of JP4324382B2 publication Critical patent/JP4324382B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002583415A 2001-04-20 2002-04-19 テトラヒドロピリジル−アルキル−複素環、その製造方法およびそれを含む医薬組成物 Expired - Fee Related JP4324382B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0105360A FR2823748B1 (fr) 2001-04-20 2001-04-20 Tetrahydropyridyl-alkyl-benzodiazines, procede pour leur preparation et compositions pharmaceutiques les contenant
FR0105362A FR2823750B1 (fr) 2001-04-20 2001-04-20 Tetrahydropyridyl-alkyl-heterocycles, procede pour leur preparation et compositions pharmaceutiques les contenant
PCT/FR2002/001343 WO2002085888A1 (fr) 2001-04-20 2002-04-19 Tetrahydropyridyl-alkyl-heterocycles, procede pour leur preparation et compositions pharmaceutiques les contenants

Publications (3)

Publication Number Publication Date
JP2004525983A JP2004525983A (ja) 2004-08-26
JP2004525983A5 true JP2004525983A5 (https=) 2009-06-18
JP4324382B2 JP4324382B2 (ja) 2009-09-02

Family

ID=26212980

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002583415A Expired - Fee Related JP4324382B2 (ja) 2001-04-20 2002-04-19 テトラヒドロピリジル−アルキル−複素環、その製造方法およびそれを含む医薬組成物

Country Status (6)

Country Link
US (1) US7186720B2 (https=)
EP (1) EP1383762B1 (https=)
JP (1) JP4324382B2 (https=)
AT (1) ATE365162T1 (https=)
DE (1) DE60220779T2 (https=)
WO (1) WO2002085888A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2831166B1 (fr) * 2001-10-18 2004-02-27 Sanofi Synthelabo Aralkyl-tetrahydro-pyridines, leur preparation et compositions pharmaceutiques les contenant
US7759337B2 (en) 2005-03-03 2010-07-20 Amgen Inc. Phthalazine compounds and methods of use
FR2883285B1 (fr) * 2005-03-17 2007-05-18 Sanofi Aventis Sa Sel besylate de la 7-(2-(4-(3-trifluoromethyl-phenyl) -1,2,3,6-tetrahudro-pyrid-1-yl)ethyl) isoquinoleine, sa preparation et son utilisation en therapeutique
US7662824B2 (en) * 2005-03-18 2010-02-16 Janssen Pharmaceutica Nv Acylhydrazones as kinase modulators
HRP20170103T1 (hr) 2005-12-21 2017-03-24 Janssen Pharmaceutica N.V. Triazolopiridazini kao modulatori tirozin kinaze
US8772481B2 (en) 2008-10-10 2014-07-08 Amgen Inc. Aza- and diaza-phthalazine compounds as P38 map kinase modulators and methods of use thereof
US8497269B2 (en) 2008-10-10 2013-07-30 Amgen Inc. Phthalazine compounds as p38 map kinase modulators and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421641A1 (de) * 1984-06-09 1985-12-12 Merck Patent Gmbh, 6100 Darmstadt Indolderivate
FR2736053B1 (fr) * 1995-06-28 1997-09-19 Sanofi Sa Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines
FR2762514B1 (fr) 1997-04-29 1999-10-22 Sanofi Sa Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation

Similar Documents

Publication Publication Date Title
DK172809B1 (da) Heterocycliske forbindelser og fremgangsmåde til deres fremstilling
AU732863B2 (en) Indole derivatives having combined 5HT1A, 5HT1B and 5HT1D receptor antagonist activity
PE20081378A1 (es) Derivados de 1,2,4-triazol como moduladores de mglur5
JP2007517010A5 (https=)
JP2005518371A5 (https=)
WO2007070506B1 (en) Diaza heterocyclic sulfonamide derivatives and their uses
DK200001556A (da) Substituerede thiazolidindionderivater
PE20001484A1 (es) Derivados de naftalen-1-ilo urea y acido carbamico
RU2009121564A (ru) Азаадамантановые производные и способы применения
IE62113B1 (en) Thiadiazinones
ATE458483T1 (de) Selektive pyrimidin-a2b-antagonistenverbindungen, ihre synthese und verwendung
JP2020533347A5 (https=)
DE602005005167D1 (de) 1-isopropyl-2-oxo-1,2-dihydropyridin-3-carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor
KR960017658A (ko) 알파₁-아드레날린수용체 길항물질로서의 [3-(4-페닐피페라진-1-일)프로필-아미노, 티오 및 옥시]-피리딘, 피리미딘 및 벤젠 유도체
RU98117621A (ru) Новые производные пиперазина и пиперидина, способ их получения, фармкомпозиция на их основе, способ лечения, промежуточный продукт
KR950002587A (ko) 농약
JP2004525983A5 (https=)
MXPA05011270A (es) Compuestos de imidazopiridina que tienen actividad agonista del receptor 5-ht4 y actividad antagonista del receptor 5-ht3.
JPH11302279A (ja) 新規なピペラジン及びピペリジン化合物
JP2024519815A5 (https=)
KR840006633A (ko) 벤족사졸리논 유도체의 제조방법
BRPI0709101A2 (pt) derivados de triazolona e medicamento e agente terapêutico e/ou profilático compreendendo os mesmos
AR045791A1 (es) Derivados de triazol sustituidos como antagonistas de oxitocina
AU702609B2 (en) Pyridylthio compounds for controlling helicobacter bacteria
HU220062B (hu) Helyettesített alkil-tio-piridinil-metil-tio-benzimidazol és -imidazo[4,5-b]piridin-származékok és felhasználásuk gyógyszerkészítmények előállítására